AFP and liver cancer: Some studies have shown that PIVKA-II was superior to other markers (alpha-fetoprotein [AFP] and lens culinaris agglutinin-reactive fraction of AFP [AFP-L3%]) in differentiating primary liver cancer from cirrhosis [6].